Form 4: Imunon Inc. Insider Trades: Lindborg Acquires Stock

Stacy Lindborg, President and CEO of Imunon, Inc., acquired 67,150 shares of common stock on June 25, 2026, valued at $1.72 per share, as part of her 2025 annual bonus.

Summary

• Stacy Lindborg, President and CEO and Director of Imunon, Inc., acquired 67,150 shares of common stock on June 25, 2026.
• The acquisition was made in lieu of 50% of her 2025 annual cash bonus.
• The shares were acquired at a price of $1.72 per share.
• Following this transaction, Lindborg beneficially owns 778 shares of common stock directly, with an additional 778 shares held indirectly through a 401(k) Plan.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral to slightly positive event. While insider buying is generally positive, the acquisition being in lieu of cash compensation and the relatively small amount of shares acquired temper the positive sentiment.

Positives

• Insider acquisition of stock by a key executive (President and CEO) can signal confidence in the company's future prospects.
• The acquisition is part of a bonus, indicating that performance targets may have been met or that compensation is being structured in a way that aligns executive interests with shareholders.

Negatives

• The acquisition is in lieu of cash, which could imply a cash constraint for the company or a strategic decision to conserve cash.
• The number of shares acquired is relatively small compared to the total outstanding shares, suggesting it may not be a significant strategic investment.

Risks

• The filing does not explicitly mention any risks associated with this transaction.
• General risks associated with Imunon, Inc. and its business operations, as detailed in other SEC filings, would still apply.

Future Outlook

This filing is a statement of changes in beneficial ownership and does not contain forward-looking statements or guidance regarding the company's future financial performance.

Management Comments

• Stock granted in lieu of cash for 50% of 2025 annual cash bonus.

Industry Context

StockSavvy.ai notes that insider stock acquisitions, especially by C-suite executives, are often viewed positively by the market as they can indicate management's belief in the company's value and future growth potential. However, the context of this acquisition being in lieu of cash compensation is also important to consider.

Stakeholder Impact

• Shareholders: May view the insider acquisition positively, signaling confidence, but the 'in lieu of cash' aspect might raise questions about company liquidity or executive compensation structure.
• Employees: The transaction relates to executive compensation and may not have a direct impact on other employees.
• Management: Stacy Lindborg's beneficial ownership increases, aligning her interests more closely with shareholders.

Next Steps

• Continued monitoring of Imunon, Inc.'s operational and financial performance.
• Observation of any further insider transactions or disclosures.

Key Dates

Keywords

Imunon Inc., IMNN, Form 4, Insider Trading, Stock Acquisition, Executive Compensation, Stacy Lindborg, Beneficial Ownership, SEC Filing